Eli Lilly & Co. (LLY): Price and Financial Metrics
LLY Price/Volume Stats
| Current price | $908.27 | 52-week high | $972.53 |
| Prev. close | $902.71 | 52-week low | $516.57 |
| Day low | $895.92 | Volume | 2,405,900 |
| Day high | $915.43 | Avg. volume | 3,059,397 |
| 50-day MA | $895.04 | Dividend yield | 0.58% |
| 200-day MA | $767.21 | Market Cap | 863.22B |
LLY Stock Price Chart Interactive Chart >
Eli Lilly & Co. (LLY) Company Bio
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Col. Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War. (Source:Wikipedia)
Latest LLY News From Around the Web
Below are the latest news stories about ELI LILLY & CO that investors may wish to consider to help them evaluate LLY as an investment opportunity.
2024’s Power Players: 7 Stocks Racing to a Trillion ValuationWhether in 2024, or in the years ahead, each of these seven stocks could become the next trillion dollar companies. |
3 Ken Griffin Stocks to Invest Like CitadelInvest like Citadel founder and billionaire Ken Griffin with these stocks that have strong potential heading into 2024. |
Top 3 Large-Cap Growth Stock Picks for the New YearCrisis is creating opportunity for investors with some of these large-cap growth stocks for New Year 2024. |
Why Fusion Pharmaceuticals (FUSN) Stock Was Up 14% on WednesdayFusion Pharmaceuticals (FUSN) surges to a new record level 52-week high after analysts at Raymond James upgraded its rating following the buyout announcements for two comparable companies. |
New weight loss drugs are out of reach for millions of older Americans because Medicare won't payNew obesity drugs are showing promising results in helping some people shed pounds but the injections will remain out of reach for millions of older Americans because Medicare is forbidden to cover such medications. As obesity rates rise among older adults, some lawmakers say the United States cannot afford to keep a decades-old law that prohibits Medicare from paying for new weight loss drugs, including Wegovy and Zepbound. A look at the debate around if — and how — Medicare should cover obesity drugs: WHAT OBESITY DRUGS ARE ON THE MARKET AND HOW DO THEY WORK? |
LLY Price Returns
| 1-mo | 2.00% |
| 3-mo | 4.87% |
| 6-mo | 19.77% |
| 1-year | 53.53% |
| 3-year | 291.36% |
| 5-year | 772.91% |
| YTD | 56.57% |
| 2023 | 60.91% |
| 2022 | 34.26% |
| 2021 | 66.08% |
| 2020 | 31.04% |
| 2019 | 16.14% |
LLY Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Continue Researching LLY
Want to see what other sources are saying about ELI LILLY & Co's financials and stock price? Try the links below:ELI LILLY & Co (LLY) Stock Price | Nasdaq
ELI LILLY & Co (LLY) Stock Quote, History and News - Yahoo Finance
ELI LILLY & Co (LLY) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...